Navigation Links
Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
Date:8/2/2012

PINE BROOK, N.J., Aug. 2, 2012 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing countermeasures for biodefense, announced today that it has been awarded additional funding from the U.S. Government, valued at $50.2 million, for the advanced development of ETI-204 (Anthim), an investigational agent for the treatment of anthrax infection following a biowarfare attack.  Anthrax is a life-threatening infectious disease caused by the bacterium Bacillus anthracis. Much of the morbidity and mortality of anthrax can be attributed to anthrax toxins. Anthrax remains one of the nation's top biowarfare threats. Inhaled anthrax is often fatal, despite treatment with antibiotics. ETI-204 is an investigational anti-toxin and is a promising candidate for the treatment of inhalational anthrax in humans.

(Logo: http://photos.prnewswire.com/prnh/20090420/NY01624LOGO)

The $50.2 million awarded by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, will be used to conduct definitive efficacy studies in animals and complete validation of the commercial manufacturing process for ETI-204. This third year of funding is in addition to $57.5 million the company already received under this contract and is part of a five year award totaling up to $143 million. This advanced product development contract is supporting Elusys' efforts to gain U.S. Food and Drug Administration (FDA) licensure, including manufacturing activities, human safety trials and non-clinical effectiveness studies in animals.

"We are pleased that the U.S. Government is continuing to support our efforts to advance ETI-204 through the final stages of our development program, including validation of our commercial manufacturing pro
'/>"/>

SOURCE Elusys Therapeutic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Tom Karagiannis, Ph.D. Awarded Future Fellowship by Australian Research Council (ARC)
2. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
3. Engineer-turned-librarian awarded travel stipend by SPIE Digital Library
4. Delpor Awarded $340K NIH Grant for 3-month Long Acting Risperidone Product in order to Improve Medication Adherence in Schizophrenia and Bipolar Disorder
5. Produce Safety Researchers Awarded by ABC Research Laboratories
6. Cohera Medical Awarded Platform Patent on its Biodegradable Adhesive Technology
7. CELEXION Awarded Patent on Biosynthesis of Renewable Chemicals
8. Chemring Detection Systems Awarded $9M for Biological Detection Systems
9. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
10. Chemring Detection Systems Awarded $500k for Strategic Research and Development
11. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... (PRWEB) December 23, 2014 On ... law H.R. 83, the Omnibus and Continuing Resolution ... time, made hydrocephalus a condition eligible to receive ... (CDMRP) administered by the Department of Defense (DoD). ... its allies on Capitol Hill, is celebrating this ...
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)...  Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... Trial Application (CTA) with the United Kingdom,s ... regulatory approval to initiate clinical trials for the continued ... Contingent on the Company receiving CTA regulatory approval, the ... assess the safety, tolerability and dose escalation of Anatabine ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
Breaking Biology Technology:Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3ALNE Announces Intention To Acquire BioTechPharma 2
... Ind., June 30 Zimmer Holdings, Inc. (NYSE: ZMH ... earnings conference call will be broadcast live over the Internet on ... news release detailing the quarterly results will be made available at ... The live audio webcast can be accessed via Zimmer,s Investor Relations ...
... 30 In connection with its proposed acquisition of London ... June 5 2009, Inverness Medical Innovations, Inc. (NYSE: ... to remind Inverness shareholders through this announcement of their dealing ... , , Dealing disclosure requirements of the UK ...
... Quarter 2009 Earnings Conference Call Tuesday, August 4, 2009, 5:00 p.m. U.S. ... (Nasdaq: CEPH ) has scheduled its regular quarterly earnings conference call covering ... , , August 4, 2009 Schedule , , ... PRNewswire, 4:50 p.m. EDT To participate in the conference ...
Cached Biology Technology:Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements. 2
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here before: ... but can,t remember your password, site key or the answer ... your first grade teacher? Today, Hoyos ... app that will finally put an end to the ... 1U TM . 1U leverages a user,s smartphone to ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... such as schizophrenia, major depression and cancer are ... dysfunctional genes. A novel computational biology method developed ... PhD, http://www.njit.edu/news/2008/2008-367.php , associate professor in NJIT,s ... a way to uncover the critical genes responsible ...
... WEST LAFAYETTE, Ind. Although research has linked inbreeding ... of animals, a new study finds it plays no ... Purdue University researchers recently examined 2,000 adult and ... deformities, mainly consisting of missing, extra or dwarfed digits ...
... NEW YORK, NY (October 28, 2008) The first ... exploring the role of hospital touch surfaces in the ... researchers reported their findings in a poster session at ... in Washington, D.C. on Tuesday, October 28. The ...
Cached Biology News:NJIT professor finds engineering technique to identify disease-causing genes 2Study rules out inbreeding as cause of amphibian deformities 2
... pAcGHLT-A,B,C ... Vector Set,pAcGHLT-XylE ... Vector,Thrombin Powder,Thrombin ... Inhibitor Cocktail,Insect ...
... This product has been developed to significantly ... labeled proteins. Stability is increased at ... 2-8 centigrade. This product is subjected ... mercury or azide. This formulation insures ...
... been developed to significantly increase the shelf ... Stability is increased at room temperature storage ... This product is subjected to 0.45 micron ... This formulation insures consistently high levels ...
... conveniently controls the temperature at your lab bench. ... up to 99 C*, with the "plus" being ... 5 C. The thermoblocks for 0.2 ml**, 0.5 ... enable a high degree of flexibility for a ...
Biology Products: